retatrutide or semaglutide vs Mounjaro vs Ozempic: 2026 Data Is Decisive switching from semaglutide to retatrutide

The STEP trials are testing semaglutide at the higher dose of 2.4 mg/week (as compared to 1.0 mg/week for the original diabetes indication), specifically for promoting weight loss, regardless of the presence of type 2 diabetes

GLP-1 GLP-1 injection GLP-1 GLP-1 GLP-1 GLP-1 1 GLP-1 1 2GLP-1 3GLP

A Changing Landscape: FDA Rescinds Shortage Designation In February 2025, the FDA removed semaglutide from the drug shortage list

Meanwhile, Eli Lilly is conducting trials to test new drugs that work similarly to Zepbound

The most commonly reported adverse effects of these medications are gastrointestinal in nature

You can read our real google reviews for yourself